Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b, multicenter, randomized, open-label, noninferiority study, the incidences of clinical events, renal dysfunction, and adverse events (AEs) were ana...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
2017
|
| Online Access: | https://doi.org/10.1111/ajt.14215 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.14215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|